Drug discovery tools
Bespoke, innovative, and sustainable technologies for drug discovery.
We accelerate and transform drug discovery by integrating next-generation technologies and products into the design-make-test-analyse cycle. With expertise spanning from biology to engineering, we create tailored solutions for pharma and companies developing tools for the industry, helping our clients in keeping pace with the rapidly changing industry landscape.
Seamless integration with existing systems and workflows
Drug discovery is evolving rapidly as advances in AI, automation, microfluidics and next-generation biological models transform how new therapeutics are discovered, developed and validated. TTP partners with pharmaceutical, biotechnology and life science companies to develop bespoke technologies that accelerate innovation, reduce technical risk and bring new capabilities into the laboratory.
Our multidisciplinary team combines expertise in biology, chemistry, engineering, software, optics and manufacturing to develop novel instruments, automation platforms, microfluidic systems and consumables tailored to each client's needs. Whether you're developing a new research tool, scaling an emerging technology, automating complex laboratory workflows or translating an early concept into a manufacturable product, we help turn ambitious ideas into practical, commercially successful solutions.
Partnering with TTP means accessing a large team of passionate technologists and innovators dedicated to helping you stay at the forefront of drug discovery.
TTP has a world-class reputation for excellence in developing highly complex instrumentation effectively. Their multi-disciplinary team are highly experienced and were able to deliver in a variety of areas from optics to fluidics, from software to systems integration, very quickly. This, coupled with their commercial acumen and drive to bring our idea to reality, made them our ideal partner.
Dr Frank Craig
CEO and Director at Sphere Fluidics
The multi-disciplinary team at TTP are highly experienced and were able to rapidly assist us in the manufacturing of MosaiQ to build what is now an industry leading system. Their expertise, together with their drive to bring our idea to reality, made them the ideal partner.
Ed Farrell
Formerly President at Quotient
Streamline every step of your drug discovery platform
As recent policy developments aim to make drugs more affordable and sustainable, pharmaceutical companies are embracing innovation to streamline every phase of discovery.
Non-contact dispensing enables seamless sample transfer, for example, while lab automation links up the make and test phases of the drug discovery cycle through chemical synthesis, sample scheduling and cell-based screening assays.
At TTP, we go beyond standard solutions, developing bespoke technologies tailored to solve specific bottlenecks to improve workflow efficiency.
Accelerating the next generation of drug discovery
AI is transforming how drug candidates are designed, but faster molecular design is only part of the equation. To unlock the full potential of AI-driven discovery, the entire Design-Make-Test-Analyse (DMTA) cycle must become faster, more integrated and more scalable.
Explore our latest insight series to discover how emerging technologies, automation and new approaches to synthesis, purification and testing are reshaping the future of drug discovery, and what it will take to build high-velocity DMTA workflows.
Miniaturisation for sustainability
Sustainability in drug discovery can enormously benefit from innovative technology. TTP is leading the way with advanced miniaturisation solutions like microfluidics and droplet printing, enabling high-density data generation while dramatically reducing both lab footprint and plastic waste relative to traditional microplates.
With deep expertise in microfluidic system design—from complex micro-fabrication and fluidic interfaces to full benchtop instrument design and manufacturing transfer—TTP delivers the technology solutions pharmaceutical companies need for efficient, sustainable innovation. Our proprietary SureDrop technology brings nanolitre droplet-based assays – ideal for sensitive cell applications – within reach, while we also offer complementary capabilities in optics and software.
Learn how miniaturisation technologies are driving sustainable innovation in drug discovery.
Supporting the development of screening tools
To serve the pharma industry, many developers of novel screening and analytic tools need to enhance their offering with high-throughput screening capability and push the boundaries of reliability,usability, and analytical power.
TTP’s in-depth expertise in the foundational sciences of physics, chemistry and biology allows us to support the engineering design and development of next-generation screening and analytical tools for drug discovery.
Our insight will be backed up by rigorous testing, from the mechanical functionalities to biological performance, to command the confidence of your development team. We can either work alongside your team or independently develop instrumentation for manufacturing at scale.
Meet some of the team
Wenshu Xu
Greg Walkowiak
Jon Wingfield
Software capability at TTP
Engages in all stages of software and product development, our software capability at TTP covers the full spectrum–from in-depth analysis and system architecture, to prototype design, implementation and development.
Manufacturing capability at TTP
Working seamlessly with our development teams, we take clients’ products through prototype builds, clinical trials, pilot manufacturing and more. Using TTP Manufacturing reduces uncertainty, risk and time to market for our clients.
